Perfusion Medical


Perfusion Medical is dedicated to commercializing PEG-20k, a revolutionary drug designed to treat hemorrhagic shock and other ischemic conditions. With over $18 million in funding from the Department of Defense and numerous studies supporting its efficacy, the company aims to improve patient outcomes significantly.

Perfusion Medical Logo

Perfusion Medical

12110 Sunset Hills Rd Suite 600, Reston, VA 20190, USA; 800 East Leigh Street, Richmond, VA 23219, USA


What We Do

PEG-20k is an investigational drug that addresses capillary compression due to ischemia, aiming to improve tissue perfusion and oxygen transfer in patients suffering from hemorrhagic shock and other ischemic injuries.



Key People

Gerard Eldering

Chief Executive Officer

LinkedIn

Dr. Martin Mangino, PhD

Inventor

LinkedIn

Rob Collins

Chief Business Officer

LinkedIn

Dr. Frank Booth

Chief Medical Officer

LinkedIn

Curt Scribner

Regulatory Lead

LinkedIn

Dave Hughes

CMC Lead

LinkedIn

Frank Del Greco

Project Manager

LinkedIn

Dr. Loren Liebrecht

Chief Research Medical Officer

LinkedIn